Literature DB >> 29243610

Azuki bean (Vigna angularis) extract inhibits the development of experimentally induced atopic dermatitis-like skin lesions in NC/Nga mice.

Therese Marie Collantes1, Mun-Chual Rho2, Hyoung-Jun Kwon2, Bock-Gie Jung1, Mia Madel Alfajaro1, Deok-Song Kim1, Hyun-Jeong Kim1, Myra Hosmillo1, Jun-Gyu Park1, Kyu-Yeol Son1, Sang-Ik Park1, Mun-Il Kang1, Su-Jin Park2, Seung Woong Lee2, Woo-Song Lee2, Kyoung-Oh Cho3.   

Abstract

The present study investigated the effects of azuki bean (Vigna angularis) extract (VAE) on the progress of atopic dermatitis (AD)-like skin lesions in NC/Nga mice induced by 1-chloro-2,4-dinitrobenzene. The efficacy of VAE in NC/Nga mice was determined by measuring gross and histological skin lesions, serum IgE levels, eosinophil ratio in peripheral leucocytes, and mRNA expression levels of interleukin (IL)-4, tumour necrosis factor (TNF)-α and interferon (IFN)-γ in splenocytes. Continuous ingestion of VAE inhibited the development of the AD-like skin lesions in a dose-dependent manner. In the VAE-treated mice, the numbers of mast cells in the skin, eosinophil ratio in peripheral leucocytes, relative mRNA expression of inflammatory cytokines in the spleen, and serum IgE levels were significantly reduced. Results suggest that VAE can inhibit the development of AD-like skin lesions in NC/Nga mice by regulating immune mediators and cells, and may be an effective alternative therapy for AD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Atopic dermatitis; Azuki bean; IgE; Immune cells; Inflammatory cytokines; NC/Nga mice

Year:  2011        PMID: 29243610     DOI: 10.1016/j.foodchem.2011.11.100

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  1 in total

1.  Extract from Black Soybean Cultivar A63 Extract Ameliorates Atopic Dermatitis-like Skin Inflammation in an Oxazolone-Induced Murine Model.

Authors:  Banzragch Dorjsembe; Chu Won Nho; Yongsoo Choi; Jin-Chul Kim
Journal:  Molecules       Date:  2022-04-25       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.